Point Of Care Infectious Disease Diagnostics Market Synopsis:
Point Of Care Infectious Disease Diagnostics Market Size Was Valued at USD11.42 Billion in 2023, and is Projected to Reach USD 16.97 Billion by 2032, Growing at a CAGR of 4.5 % From 2024-2032.
The Point of Care (POC) Infectious Disease Diagnostics market deals with portable or handheld equipment and tests that are often conducted, or very near the patient treatment location for confirmation of an infectious disease such as HIV, tropical diseases, liver diseases, respiratory infections among others. These tests are fast since no samples have to be taken to other centralized facilities for further testing to be conducted. The aim is to note three trends which have stimulated the utilization of POC diagnostic technologies: there was found out increase in use of fast and accurate diagnostic methods especially in emergent or remote practices. These tests are applicable within the surroundings of hospitals and clinics, the homecare setting and as such the formation of an effective test is an important facet of this present day’s healthcare facility.
There are the following factors helping to explain the growth of the Point of Care Infectious Disease Diagnostics market globally: The increase in the incidence of infectious diseases all over the world, advancement of the diagnostics devices, demand for accuracy in diagnostics. POC diagnostics assists the identification of causative organisms such as bacteria, virus or parasite and places the patients on the correct treatment at the correct time. These factors include the shift in trends in lifecycle, demand for home healthcare, awareness regarding the need for decentralised healthcare among others.
Advanced in different aspects of molecular diagnose technologies have enable the growth of disposed point of care diagnostic devices market and acknowledge technology such as immunoassay, biosensors have also contributed significantly into the growth of this market. Additionally, the requirement for RDTs was evidenced with the emergence of the COVID-19 pandemic to appropriately adapt the POC diagnostics industry. Apart from all the infectious diseases, POC testing is also used for diseases that are chronic such as diabetes, hence making the market big. Going forward, as governments and healthcare organizations around the world strived to bring changes in order to enhance the delivery of healthcare services especially to the rural and underprivileged patients, the point-of-care infectious disease diagnostics market will exhibit a steady year-on-year growth owing to innovation in product that enhance diagnostics of the diseases.
Point Of Care Infectious Disease Diagnostics Market Trend Analysis:
Increased Adoption of Molecular Diagnostics
- This mirrors a trend identified in the Point of Care Infectious Disease Diagnostics market where molecular diagnostic procedures such as PCR and NAATs are being used progressively. These technologies render high sensitivity and specificity as good diagnostic tools to detect pathogens two times faster than the conventional laboratory techniques. The on-going emergence of new acute infections like COVID-19, as well as the need for rapid decision-making concerning a person’s health state, have elevated molecular diagnostics to a starring position in the POC diagnostics market. Moreover, the integration of AI and ML on diagnostic procedures has enhanced this trend further [ 10], to enhance diagnosis, test specialty and automation makes testing more accurate and accessible in various sections of the health care facility.
Expanding Market for Home and Remote Diagnostics
- Currently, there is one major trend in the Point of Care Infectious Disease Diagnostics market which is the sales of tests that can be conducted at home or through telemedicine. As for the POC diagnostic devices for person use, increasing concern for health and the possibility of the test being done from the comfort of their homes has made consumers indulge in it. This can be seen especially in infections like; sexually transmitted diseases, respiratory infections and others for which the patient may wish to diagnose without visiting the hospital or clinic. Extension of a Smartphone with a portable test kit diagnostic as a mobile application is another enhancement of this opportunity. The favourable conditions for development of POC diagnostics were promoted also by the tendencies to the remote services all over the world and, specifically, to telehealth services. Businesses have been able rather rapidly satisfy an already existing consumer demand for part of numerous at-home testing solutions that can potentially revolutionize the detection of infectious diseases globally.
Point Of Care Infectious Disease Diagnostics Market Segment Analysis:
Point Of Care Infectious Disease Diagnostics Market Segmented on the basis of Product, Application, End User, and Region
By Product, Consumables, Instrument segment is expected to dominate the market during the forecast period
- The consumables and instruments segment is expected to dominate the market over the forecast period due to their indispensability in performing rapid, accurate and efficient diagnostics. Mexippiem testing and production equipment includes diagnostic devices for which effective functioning relies on test strips, reagents, and cartridges; thus, the emphasis on quality consumable products. Thus, consumer durables need high velocity fast turn consumables, and changes in technology based diagnostic instruments make the growth of this segment. Furthermore, portable and handheld diagnostic instruments have developed in different ways in all the aspects that enable the performers to make diagnoses at the point care and reduce the delays in diagnosis that come with adverse impacts to the patients. Since development of faster and more accurate diagnostics convinced the market for this segment is expected to grow and will be substantially significant.
By Application, Respiratory Disease segment expected to held the largest share
- When analysing Point of Care Infectious Disease Diagnostics market share the largest share will be contributed by respiratory disease segment due to increasing prevalence of respiratory diseases especially in the developing world. Respiratory diseases are undoubtedly a threatening to global population and the need for point of care devices for fast identification of pathogens and guiding the management process even more crucial. The availability of more formulations of pandemics and flu seasons may extend the market of POC diagnostic devices for respiratory infections. Techniques like PCR, antigen testing, and LFAs are the norm for diagnosing respiratory diseases, and are enhancing diagnostic time, while reducing disease transmission within healthcare facilities among others. Since different healthcare industries have a focus to understand and work to eradicate infectious respiratory diseases the respiratory disease segment is expected to dominate in this market up to the forecast period.
Point Of Care Infectious Disease Diagnostics Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- North America is expected to have the largest share in the Point of Care Infectious Disease Diagnostics market in the given period because it has a sound health care infrastructure, high health care spending and increased R&D investments. Many big players of the diagnostics and overall healthcare industry are present in this region and are still in the process of further enriching their portfolios to cater to the demand of the increasing POC testing products. Still, some of the factors like the rising incidence of telemedicine applications, globally transmissible diseases, improved governmental healthcare services and initiatives towards better healthcare, and faster healthcare services are again working in the favour of North America to drag this market forward.
- United States is one of the biggest contributors of the growth in POC infectious disease diagnostics due to the Affordable Care Act and a widespread use of molecular diagnostic systems in health care institutions across the country. In addition, the rising awareness regarding early pathological detectable diseases together with some of the latest innovative point of care diagnosing instruments and methods put North American market in front of all in this segment. Therefore, having the relative strength and growth of the healthcare industry in the region and the prospect of home healthcare products in future the market has further scope of future growth.
Active Key Players in the Point Of Care Infectious Disease Diagnostics Market:
- Abbott Laboratories (USA)
- BD (Becton, Dickinson and Company) (USA)
- Cepheid (USA)
- Danaher Corporation (USA)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Grifols S.A. (Spain)
- Hologic, Inc. (USA)
- Johnson & Johnson (USA)
- Labcorp (USA)
- Meridian Bioscience, Inc. (USA)
- Mettler Toledo (Switzerland)
- Ortho Clinical Diagnostics (USA)
- Siemens Healthineers AG (Germany)
- Thermo Fisher Scientific Inc. (USA)
- BioMérieux (France)
- Other Active Players
|
Point of Care Infectious Disease Diagnostics Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 11.42 Billion |
|
Forecast Period 2024-32 CAGR: |
4.5 % |
Market Size in 2032: |
USD 16.97 Billion |
|
Segments Covered: |
By Product |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Point Of Care Infectious Disease Diagnostics Market by Product
4.1 Point Of Care Infectious Disease Diagnostics Market Snapshot and Growth Engine
4.2 Point Of Care Infectious Disease Diagnostics Market Overview
4.3 Consumables
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Consumables: Geographic Segmentation Analysis
4.4 Instruments
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Instruments: Geographic Segmentation Analysis
4.5 Software and Services
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Software and Services: Geographic Segmentation Analysis
Chapter 5: Point Of Care Infectious Disease Diagnostics Market by Application
5.1 Point Of Care Infectious Disease Diagnostics Market Snapshot and Growth Engine
5.2 Point Of Care Infectious Disease Diagnostics Market Overview
5.3 HIV
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 HIV: Geographic Segmentation Analysis
5.4 Tropical Disease
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Tropical Disease: Geographic Segmentation Analysis
5.5 Liver Disease
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Liver Disease: Geographic Segmentation Analysis
5.6 Inflammatory Disease
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Inflammatory Disease: Geographic Segmentation Analysis
5.7 Respiratory Disease
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Respiratory Disease: Geographic Segmentation Analysis
5.8 Hospital Associated Infections
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Hospital Associated Infections: Geographic Segmentation Analysis
5.9 and Sexual Health Disorders
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 and Sexual Health Disorders: Geographic Segmentation Analysis
Chapter 6: Point Of Care Infectious Disease Diagnostics Market by End User
6.1 Point Of Care Infectious Disease Diagnostics Market Snapshot and Growth Engine
6.2 Point Of Care Infectious Disease Diagnostics Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation Analysis
6.4 Healthcare Centers
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Healthcare Centers: Geographic Segmentation Analysis
6.5 Laboratories
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Laboratories: Geographic Segmentation Analysis
6.6 Independent Diagnostic Centers
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Independent Diagnostic Centers: Geographic Segmentation Analysis
6.7 and Home Care Settings
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 and Home Care Settings: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Point Of Care Infectious Disease Diagnostics Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ABBOTT LABORATORIES (USA)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 BD (BECTON
7.4 DICKINSON AND COMPANY) (USA)
7.5 CEPHEID (USA)
7.6 DANAHER CORPORATION (USA)
7.7 F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND)
7.8 GRIFOLS S.A. (SPAIN)
7.9 HOLOGIC INC. (USA)
7.10 JOHNSON & JOHNSON (USA)
7.11 LABCORP (USA)
7.12 MERIDIAN BIOSCIENCE INC. (USA)
7.13 METTLER TOLEDO (SWITZERLAND)
7.14 ORTHO CLINICAL DIAGNOSTICS (USA)
7.15 SIEMENS HEALTHINEERS AG (GERMANY)
7.16 THERMO FISHER SCIENTIFIC INC. (USA)
7.17 BIOMÉRIEUX (FRANCE)
7.18 OTHER ACTIVE PLAYERS
Chapter 8: Global Point Of Care Infectious Disease Diagnostics Market By Region
8.1 Overview
8.2. North America Point Of Care Infectious Disease Diagnostics Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Product
8.2.4.1 Consumables
8.2.4.2 Instruments
8.2.4.3 Software and Services
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 HIV
8.2.5.2 Tropical Disease
8.2.5.3 Liver Disease
8.2.5.4 Inflammatory Disease
8.2.5.5 Respiratory Disease
8.2.5.6 Hospital Associated Infections
8.2.5.7 and Sexual Health Disorders
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospitals
8.2.6.2 Healthcare Centers
8.2.6.3 Laboratories
8.2.6.4 Independent Diagnostic Centers
8.2.6.5 and Home Care Settings
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Point Of Care Infectious Disease Diagnostics Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Product
8.3.4.1 Consumables
8.3.4.2 Instruments
8.3.4.3 Software and Services
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 HIV
8.3.5.2 Tropical Disease
8.3.5.3 Liver Disease
8.3.5.4 Inflammatory Disease
8.3.5.5 Respiratory Disease
8.3.5.6 Hospital Associated Infections
8.3.5.7 and Sexual Health Disorders
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospitals
8.3.6.2 Healthcare Centers
8.3.6.3 Laboratories
8.3.6.4 Independent Diagnostic Centers
8.3.6.5 and Home Care Settings
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Point Of Care Infectious Disease Diagnostics Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Product
8.4.4.1 Consumables
8.4.4.2 Instruments
8.4.4.3 Software and Services
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 HIV
8.4.5.2 Tropical Disease
8.4.5.3 Liver Disease
8.4.5.4 Inflammatory Disease
8.4.5.5 Respiratory Disease
8.4.5.6 Hospital Associated Infections
8.4.5.7 and Sexual Health Disorders
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospitals
8.4.6.2 Healthcare Centers
8.4.6.3 Laboratories
8.4.6.4 Independent Diagnostic Centers
8.4.6.5 and Home Care Settings
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Point Of Care Infectious Disease Diagnostics Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Product
8.5.4.1 Consumables
8.5.4.2 Instruments
8.5.4.3 Software and Services
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 HIV
8.5.5.2 Tropical Disease
8.5.5.3 Liver Disease
8.5.5.4 Inflammatory Disease
8.5.5.5 Respiratory Disease
8.5.5.6 Hospital Associated Infections
8.5.5.7 and Sexual Health Disorders
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospitals
8.5.6.2 Healthcare Centers
8.5.6.3 Laboratories
8.5.6.4 Independent Diagnostic Centers
8.5.6.5 and Home Care Settings
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Point Of Care Infectious Disease Diagnostics Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Product
8.6.4.1 Consumables
8.6.4.2 Instruments
8.6.4.3 Software and Services
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 HIV
8.6.5.2 Tropical Disease
8.6.5.3 Liver Disease
8.6.5.4 Inflammatory Disease
8.6.5.5 Respiratory Disease
8.6.5.6 Hospital Associated Infections
8.6.5.7 and Sexual Health Disorders
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospitals
8.6.6.2 Healthcare Centers
8.6.6.3 Laboratories
8.6.6.4 Independent Diagnostic Centers
8.6.6.5 and Home Care Settings
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Point Of Care Infectious Disease Diagnostics Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Product
8.7.4.1 Consumables
8.7.4.2 Instruments
8.7.4.3 Software and Services
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 HIV
8.7.5.2 Tropical Disease
8.7.5.3 Liver Disease
8.7.5.4 Inflammatory Disease
8.7.5.5 Respiratory Disease
8.7.5.6 Hospital Associated Infections
8.7.5.7 and Sexual Health Disorders
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospitals
8.7.6.2 Healthcare Centers
8.7.6.3 Laboratories
8.7.6.4 Independent Diagnostic Centers
8.7.6.5 and Home Care Settings
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Point of Care Infectious Disease Diagnostics Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 11.42 Billion |
|
Forecast Period 2024-32 CAGR: |
4.5 % |
Market Size in 2032: |
USD 16.97 Billion |
|
Segments Covered: |
By Product |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
